Search hospitals > Florida > Hollywood
Memorial Regional Hospital/Joe DiMaggio Children's Hospital
Claim this profileHollywood, Florida 33021
Global Leader in Skin Cancer
Global Leader in T-Lymphoblastic Leukemia/Lymphoma
Conducts research for Uterine Tumors
Conducts research for Cancer
Conducts research for Acute Lymphoblastic Leukemia
210 reported clinical trials
16 medical researchers
Summary
Memorial Regional Hospital/Joe DiMaggio Children's Hospital is a medical facility located in Hollywood, Florida. This center is recognized for care of Skin Cancer, T-Lymphoblastic Leukemia/Lymphoma, Uterine Tumors, Cancer, Acute Lymphoblastic Leukemia and other specialties. Memorial Regional Hospital/Joe DiMaggio Children's Hospital is involved with conducting 210 clinical trials across 533 conditions. There are 16 research doctors associated with this hospital, such as Iftikhar Hanif, Luis E. Raez, Atif Hussein, and Delia C. Guaqueta.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage I
Stage III
2T-Lymphoblastic Leukemia/Lymphoma
Global LeaderStage II
Stage IV
Stage III
Top PIs
Iftikhar HanifMemorial Regional Hospital/Joe DiMaggio Children's Hospital7 years of reported clinical research
Expert in Uterine Tumors
Expert in Cancer
48 reported clinical trials
108 drugs studied
Luis E. RaezMemorial Cancer Institute7 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
11 reported clinical trials
19 drugs studied
Atif HusseinMemorial Healthcare System8 years of reported clinical research
Studies Prostate Cancer
Studies Skin Cancer
6 reported clinical trials
27 drugs studied
Delia C. GuaquetaMemorial Regional Hospital/Joe DiMaggio Children's Hospital9 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
6 reported clinical trials
15 drugs studied
Clinical Trials running at Memorial Regional Hospital/Joe DiMaggio Children's Hospital
Breast Cancer
Brain Tumor
Acute Lymphoblastic Leukemia
Lung Cancer
Acute Myeloid Leukemia
T-Lymphoblastic Leukemia/Lymphoma
Wilms Tumor
Testicular cancer
Bladder Cancer
Skin Cancer
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Memorial Regional Hospital/Joe DiMaggio Children's Hospital?
Memorial Regional Hospital/Joe DiMaggio Children's Hospital is a medical facility located in Hollywood, Florida. This center is recognized for care of Skin Cancer, T-Lymphoblastic Leukemia/Lymphoma, Uterine Tumors, Cancer, Acute Lymphoblastic Leukemia and other specialties. Memorial Regional Hospital/Joe DiMaggio Children's Hospital is involved with conducting 210 clinical trials across 533 conditions. There are 16 research doctors associated with this hospital, such as Iftikhar Hanif, Luis E. Raez, Atif Hussein, and Delia C. Guaqueta.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.